The national law firm of Parker Waichman LLP has filed a lawsuit in U.S. District Court for the Western District of Louisiana against drug manufacturers Takeda and Eli Lilly alleging the type 2 diabetes drug Actos caused a Louisiana man to develop bladder cancer.
According to the lawsuit, the plaintiff developed bladder cancer while taking the drug Actos as prescribed from 2009 to 2012. The plaintiff alleged that the defendants knew that using Actos could increase the risk of bladder cancer and failed to warn consumers about that risk. In fact, the lawsuit says a two-year carcinogenicity study performed before Actos was approved by the FDA showed drug-induced tumors in rats given doses comparable to those given in a clinical setting.
The lawsuit also cites a PROactive Study published in 2005 which allegedly showed researchers discovered a higher rate of bladder cancer among those taking Actos, but failed to include this information in the original paper.
The lawsuit alleges negligence, defective design, manufacturing defect, failure to warn, breach of express and implied warranty, fraudulent misrepresentation and concealment, negligent misrepresentation, fraud and deceit, punitive damages, violation of consumer protection statutes, state products liability acts or statutes and loss of consortium.